Fig. 1
From: Clinical sepsis phenotypes in critically ill COVID-19 patients
Distribution, characteristics, and outcome of phenotypes in patients with COVID-19 sepsis and sepsis of other origins. A Phenotype distribution and 90-day in-hospital mortality Kaplan–Meier curves for patients in the COVID-19 pre-dexamethasone cohort, COVID-19 post-dexamethasone cohort, non-COVID-19 viral pneumonia sepsis cohort, bacterial pneumonia sepsis cohort, and bacterial sepsis of non-pulmonary origin cohort. B Sex, age, body mass index (BMI), comorbidity index, Acute Physiology and Chronic Health Evaluation (APACHE) IV score, creatinine, PaO2/FiO2 ratio, temperature, and white blood cell count for each phenotype across all above-mentioned cohorts. Data in panel B are shown as percentage (sex), mean and standard error of the mean (comorbidity index) or median and interquartile range (all other variables)